Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Brickell Biotech, Inc. | Financial_Report.xls |
| EX-32.1 - CERTIFICATON OF CHIEF EXECUTIVE OFFICER - Brickell Biotech, Inc. | d268604dex321.htm |
| EX-10.8 - THIRD AMENDMENT TO CONSULTING AGREEMENT - Brickell Biotech, Inc. | d268604dex108.htm |
| EX-32.2 - CERTIFICATON OF CHIEF FINANCIAL OFFICER - Brickell Biotech, Inc. | d268604dex322.htm |
| EX-31.2 - CERTIFICATON OF CHIEF FINANCIAL OFFICER - Brickell Biotech, Inc. | d268604dex312.htm |
| EX-31.1 - CERTIFICATON OF CHIEF EXECUTIVE OFFICER - Brickell Biotech, Inc. | d268604dex311.htm |
| 10-K - FORM 10-K - Brickell Biotech, Inc. | d268604d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following registration statements:
| 1) | Registration Statements on Form S-3 (333-159103 and 333-164476) of Vical Incorporated, and |
| 2) | Registration Statements on Form S-8 (33-60826, 33-60824, 33-81602, 33-81600, 33-87972, 333-30181, 333-80681, 333-60293, 333-66254, 333-97019, 333-107581, 333-116951, 333-135266, 333-143885, and 333-169344) of Vical Incorporated; |
of our reports dated March 15, 2012, with respect to the financial statements of Vical Incorporated, and the effectiveness of internal control over financial reporting of Vical Incorporated, included in this Annual Report (Form 10-K) of Vical Incorporated for the year ended December 31, 2011.
/s/ Ernst & Young LLP
San Diego, California
March 15, 2012